HALOZYME THERAPEUTICS, INC.: revenue
| Value | {"amount": 42325000, "concept": "us-gaap:Revenues", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-12-31 |
| Status | current |
| Entity | HALOZYME THERAPEUTICS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-09-01T13:26:31.911167+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a7362ef8-147f-404e-87b1-7761b558ea5d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001159036-15-000041Retrieved: 2026-09-01T13:26:31.911167+02:00
Raw response sha256:
09ca2466c06425bbd1ba706e3a09155b…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001159036/revenue/2012-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a7362ef8-147f-404e-87b1-7761b558ea5d
History
- supersedes {"amount": 42325226, "concept": "us-gaap:Revenues", "currency": "USD"} (evidence 0001483813-13-000033)